HSBC Holdings’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-48,162
Closed -$12M 2725
2022
Q3
$12M Sell
48,162
-6,657
-12% -$1.66M 0.02% 674
2022
Q2
$13.8M Buy
54,819
+9,071
+20% +$2.28M 0.02% 644
2022
Q1
$15.1M Sell
45,748
-12,470
-21% -$4.12M 0.02% 615
2021
Q4
$21M Sell
58,218
-71,397
-55% -$25.7M 0.02% 558
2021
Q3
$42.3M Buy
129,615
+7,347
+6% +$2.4M 0.04% 334
2021
Q2
$38.3M Buy
122,268
+81,022
+196% +$25.4M 0.04% 370
2021
Q1
$13M Buy
41,246
+3,013
+8% +$952K 0.02% 629
2020
Q4
$12.3M Buy
38,233
+13,287
+53% +$4.28M 0.02% 612
2020
Q3
$6.88M Buy
24,946
+3,088
+14% +$852K 0.01% 671
2020
Q2
$5.28M Sell
21,858
-5,204
-19% -$1.26M 0.01% 687
2020
Q1
$3.98M Sell
27,062
-2,751
-9% -$405K 0.01% 721
2019
Q4
$5.07M Buy
29,813
+4,132
+16% +$703K 0.01% 776
2019
Q3
$4.57M Buy
25,681
+96
+0.4% +$17.1K 0.01% 816
2019
Q2
$6.66M Sell
25,585
-2,230
-8% -$581K 0.01% 730
2019
Q1
$7.94M Buy
27,815
+7,685
+38% +$2.19M 0.01% 670
2018
Q4
$6.54M Buy
20,130
+1,178
+6% +$383K 0.01% 714
2018
Q3
$8.52M Sell
18,952
-9,703
-34% -$4.36M 0.01% 669
2018
Q2
$11.7M Buy
28,655
+24,784
+640% +$10.1M 0.02% 561
2018
Q1
$1.13M Buy
3,871
+2,167
+127% +$630K ﹤0.01% 1163
2017
Q4
$319K Buy
+1,704
New +$319K ﹤0.01% 1586